1. Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment?
    Xun Qiu et al, 2022, iLIVER CrossRef
  2. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development
    Mario M. Alba et al, 2023, Frontiers in Physiology CrossRef
  3. Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma
    Wen-Ting Peng et al, 2018, International Journal of Molecular Sciences CrossRef

  4. GRK2 Suppresses Hepatocellular Carcinoma Metastasis and Invasion Through Down-Regulation of Prostaglandin E Receptor 2


    Nan Li et al, 2020, OncoTargets and Therapy CrossRef
  5. Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review)
    Xiaoting Sun et al, 2018, International Journal of Molecular Medicine CrossRef
  6. Germline Variants and Genetic Interactions of Several EMT Regulatory Genes Increase the Risk of HBV-Related Hepatocellular Carcinoma
    Wen-Xuan Liu et al, 2021, Frontiers in Oncology CrossRef
  7. The Biology and Chemistry of Microsomal Prostaglandin E Synthase (mPGES) - I Inhibitors for Cancer Biomedicine
    Kathiravan M K et al, 2022, Systems Biomedicine Approaches in Cancer Research CrossRef
  8. Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma
    Filippo Pelizzaro et al, 2021, Clinical and Experimental Medicine CrossRef
  9. Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular Carcinoma
    Chao Chen et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
  10. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids
    Chang Hoon Lee, 2018, Biochemical Pharmacology CrossRef
  11. Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
    Gabriel Siracusano et al, 2020, Vaccines CrossRef
  12. PGE2 synthesis and signaling in the liver physiology and pathophysiology: An update
    Erjiao Qiang et al, 2024, Prostaglandins & Other Lipid Mediators CrossRef
  13. Systems approach reveals distinct and shared signaling networks of the four PGE 2 receptors in T cells
    Anna M. Lone et al, 2021, Science Signaling CrossRef
  14. High expression of Snail and NF-κB predicts poor survival in Chinese hepatocellular carcinoma patients
    Min Zhang et al, 2017, Oncotarget CrossRef
  15. Eicosanoids and cancer
    Renata Nascimento Gomes et al, 2018, Clinics CrossRef
  16. Study on Antipyretic Properties of Phenolics in Lonicerae Japonicae Flos Based on Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectrometry Combined with Network Pharmacology
    Lewen Xiong et al, 2023, Journal of Food Biochemistry CrossRef
  17. FADS1 promotes the progression of laryngeal squamous cell carcinoma through activating AKT/mTOR signaling
    Rui Zhao et al, 2020, Cell Death & Disease CrossRef
  18. Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models
    Lorena Lobos-González et al, 2023, International Journal of Molecular Sciences CrossRef
  19. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor
    MINGZHAN DU et al, 2015, Oncology Reports CrossRef
  20. Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis
    Gianenrico Rovati et al, 2022, Cells CrossRef
  21. Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
    G O'Callaghan et al, 2015, British Journal of Pharmacology CrossRef